Estradiol 66 pmol/L and Downregulation
An estradiol level of 66 pmol/L (approximately 18 pg/mL) is insufficient to cause meaningful estrogen-mediated downregulation of the hypothalamic-pituitary-gonadal axis. This concentration falls well below the threshold needed for systemic estrogenic effects, including gonadotropin suppression.
Understanding the Threshold for Downregulation
The evidence clearly demonstrates that systemic estrogen effects, including LH and FSH suppression (downregulation), require substantially higher estradiol concentrations than 66 pmol/L:
- Systemic-dose vaginal estrogen (CEE 0.625-2.5 mg daily) is required to produce LH and FSH suppression 1
- Low-dose vaginal estrogen preparations maintain estradiol levels within the normal postmenopausal range (typically <100 pmol/L or <27 pg/mL) and do not produce systemic effects 1
- The 25-µg intermediate-dose estradiol tablets increase plasma estradiol from baseline 11.3 pmol/L to only 72.5 pmol/L (19.8 pg/mL) by day 7, and even this level shows only "some systemic absorption" without clear evidence of complete gonadotropin suppression 1
Clinical Context
Your estradiol level of 66 pmol/L (18 pg/mL) represents:
- A concentration consistent with the postmenopausal range, where endogenous estrogen production is minimal
- Below the threshold for therapeutic feminization in gender-affirming therapy (guidelines suggest 367-734 pmol/L or 100-200 pg/mL, though evidence for this range is limited) 2
- Insufficient for bone protection or vasomotor symptom relief in menopausal hormone therapy
- Well below levels that suppress gonadotropins - you would expect elevated LH and FSH at this concentration, not suppression
Mechanism Considerations
While cellular-level estrogen receptor downregulation can occur at lower concentrations in vitro 3, this does not translate to clinically meaningful hypothalamic-pituitary axis suppression. The FDA labeling confirms that circulating estrogens modulate pituitary gonadotropin secretion through negative feedback, but this requires therapeutic estradiol concentrations 4.
At 66 pmol/L, you have not achieved downregulation of the HPG axis. If you are attempting to suppress gonadotropins (for any clinical indication), this estradiol level is inadequate and the dose should be increased substantially.